{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:41Z","timestamp":1790946701443,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016112","name":"Universit\u00e0 di Foggia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the pathogenesis of several rheumatic diseases, such as rheumatoid arthritis, spondyloarthritis, osteoarthritis, osteoporosis, alterations in osteoblast growth, differentiation and activity play a role. In particular, in rheumatoid arthritis bone homeostasis is perturbed: in addition to stimulating the pathologic bone resorption process performed by osteoclasts in course of rheumatoid arthritis, proinflammatory cytokines (such as Tumor Necrosis factor-\u03b1, Interleukin-1) can also inhibit osteoblast differentiation and function, resulting in net bone loss. Mouse models of rheumatoid arthritis showed that complete resolution of inflammation (with maximal reduction in the expression of pro-inflammatory factors) is crucial for bone healing, performed by osteoblasts activity. In fact, abnormal activity of factors and systems involved in osteoblast function in these patients has been described. A better understanding of the pathogenic mechanisms involved in osteoblast dysregulation could contribute to explain the generalized and focal articular bone loss found in rheumatoid arthritis. Nevertheless, these aspects have not been frequently and directly evaluated in studies. This review article is focused on analysis of the current knowledge about the role of osteoblast dysregulation occurring in rheumatoid arthritis: a better knowledge of these mechanisms could contribute to the realization of new therapeutic strategies.<\/jats:p>","DOI":"10.1007\/s11033-021-06288-y","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T19:02:47Z","timestamp":1616871767000},"page":"2843-2852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Osteoblast role in the pathogenesis of rheumatoid arthritis"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Berardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Maruotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. P.","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,27]]},"reference":[{"key":"6288_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4","journal-title":"Lancet"},{"key":"6288_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/rheumatology\/kep044","volume":"48","author":"D Morimoto","year":"2009","unstructured":"Morimoto D, Kuroda S, Kizawa T et al (2009) Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis. Rheumatology 48:643\u2013649. https:\/\/doi.org\/10.1093\/rheumatology\/kep044","journal-title":"Rheumatology"},{"key":"6288_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14656566.2015.997709","volume":"16","author":"JN Hoes","year":"2015","unstructured":"Hoes JN, Bultink IEM, Lems WF (2015) Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother 16:559\u2013571. https:\/\/doi.org\/10.1517\/14656566.2015.997709","journal-title":"Expert Opin Pharmacother"},{"key":"6288_CR4","doi-asserted-by":"publisher","first-page":"e5262","DOI":"10.1097\/MD.0000000000005262","volume":"95","author":"B Chen","year":"2016","unstructured":"Chen B, Cheng G, Wang H, Feng Y (2016) Increased risk of vertebral fracture in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 95:e5262. https:\/\/doi.org\/10.1097\/MD.0000000000005262","journal-title":"Medicine (Baltimore)"},{"key":"6288_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8515-6","volume":"51","author":"R Baum","year":"2016","unstructured":"Baum R, Gravallese EM (2016) Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts. Clin Rev Allergy Immunol 51:1\u201315. https:\/\/doi.org\/10.1007\/s12016-015-8515-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"6288_CR6","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1359\/jbmr.090320","volume":"24","author":"NC Walsh","year":"2009","unstructured":"Walsh NC, Reinwald S, Manning CA et al (2009) Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 24:1572\u20131585. https:\/\/doi.org\/10.1359\/jbmr.090320","journal-title":"J Bone Miner Res"},{"key":"6288_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"B Zhao","year":"2017","unstructured":"Zhao B (2017) TNF and bone remodeling. Curr Osteoporos Rep 15:126\u2013134. https:\/\/doi.org\/10.1007\/s11914-017-0358-z","journal-title":"Curr Osteoporos Rep"},{"key":"6288_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.2003.008458","volume":"63","author":"D O\u2019Gradaigh","year":"2004","unstructured":"O\u2019Gradaigh D, Ireland D, Bord S, Compston JE (2004) Joint erosion in rheumatoid arthritis: Interactions between tumour necrosis factor \u03b1, interleukin 1, and receptor activator of nuclear factor \u03baB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 63:354\u2013359. https:\/\/doi.org\/10.1136\/ard.2003.008458","journal-title":"Ann Rheum Dis"},{"key":"6288_CR9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/art.33504","volume":"64","author":"MM Matzelle","year":"2012","unstructured":"Matzelle MM, Gallant MA, Condon KW et al (2012) Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum 64:1540\u20131550. https:\/\/doi.org\/10.1002\/art.33504","journal-title":"Arthritis Rheum"},{"key":"6288_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-319-78127-3","volume":"1060","author":"JD Turner","year":"2018","unstructured":"Turner JD, Naylor AJ, Christopher B, Filer A, Tak PP (2018) Fibroblasts and osteoblasts in inflammation and bone damage. Stromal Immunol 1060:37\u201354. https:\/\/doi.org\/10.1007\/978-3-319-78127-3","journal-title":"Stromal Immunol"},{"key":"6288_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00441-010-1086-1","volume":"343","author":"A Neve","year":"2011","unstructured":"Neve A, Corrado A, Cantatore FP (2011) Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 343:289\u2013302. https:\/\/doi.org\/10.1007\/s00441-010-1086-1","journal-title":"Cell Tissue Res"},{"key":"6288_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ebiom.2019.02.009","volume":"41","author":"X He","year":"2019","unstructured":"He X, Liu J, Liang C et al (2019) Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis. EBioMedicine 41:538\u2013555. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.009","journal-title":"EBioMedicine"},{"key":"6288_CR13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/ijms18061272","volume":"18","author":"A Corrado","year":"2017","unstructured":"Corrado A, Maruotti N, Cantatore FP (2017) Osteoblast role in rheumatic diseases. Int J Mol Sci 18:1272. https:\/\/doi.org\/10.3390\/ijms18061272","journal-title":"Int J Mol Sci"},{"key":"6288_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.10.013","volume":"49","author":"AT Shaw","year":"2016","unstructured":"Shaw AT, Gravallese EM (2016) Mediators of inflammation and bone remodeling in rheumatic disease. Semin Cell Dev Biol 49:2\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2015.10.013","journal-title":"Semin Cell Dev Biol"},{"key":"6288_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.106.3.915","volume":"106","author":"JL Wrana","year":"1988","unstructured":"Wrana JL (1988) Differential effects of transforming growth factor-13 on the synthesis of extracellular matin proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915\u2013924. https:\/\/doi.org\/10.1083\/jcb.106.3.915","journal-title":"J Cell Biol"},{"key":"6288_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/endo-123-1-98","volume":"123","author":"RK Globus","year":"1988","unstructured":"Globus RK, Patterson-buckendahl P, Gospodarowicz D (1988) Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth. Endocrinology 123:98\u2013105","journal-title":"Endocrinology"},{"key":"6288_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","volume":"561","author":"M Capulli","year":"2014","unstructured":"Capulli M, Paone R, Rucci N (2014) Osteoblast and osteocyte: games without frontiers. Arch Biochem Biophys 561:3\u201312. https:\/\/doi.org\/10.1016\/j.abb.2014.05.003","journal-title":"Arch Biochem Biophys"},{"key":"6288_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","volume":"102","author":"JH Shim","year":"2018","unstructured":"Shim JH, Stavre Z, Gravallese EM (2018) Bone loss in rheumatoid arthritis: basic mechanisms and clinical implications. Calcif Tissue Int 102:533\u2013546. https:\/\/doi.org\/10.1007\/s00223-017-0373-1","journal-title":"Calcif Tissue Int"},{"key":"6288_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X12438080","volume":"4","author":"P Geusens","year":"2012","unstructured":"Geusens P (2012) The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis. Ther Adv Musculoskelet Dis 4:225\u2013233. https:\/\/doi.org\/10.1177\/1759720X12438080","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"6288_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000371845","volume":"61","author":"V Nagy","year":"2015","unstructured":"Nagy V, Penninger M (2015) The RANKL-RANK story. Gerontology 61:534\u2013542. https:\/\/doi.org\/10.1159\/000371845","journal-title":"Gerontology"},{"key":"6288_CR21","first-page":"204","volume":"8","author":"MP Yavropoulou","year":"2008","unstructured":"Yavropoulou MP, Yovos JG (2008) Osteoclastogenesis: current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8:204\u2013216","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"6288_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0014-5793(00)02231-6","volume":"486","author":"M Matsumoto","year":"2000","unstructured":"Matsumoto M, Sudo T, Maruyama M et al (2000) Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett 486:23\u201328. https:\/\/doi.org\/10.1016\/s0014-5793(00)02231-6","journal-title":"FEBS Lett"},{"key":"6288_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL \u2013 RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325. https:\/\/doi.org\/10.1016\/j.molmed.2005.11.007","journal-title":"Trends Mol Med"},{"key":"6288_CR24","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2014","unstructured":"Khosla S (2014) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055. https:\/\/doi.org\/10.1210\/endo.142.12.8536","journal-title":"Endocrinology"},{"key":"6288_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass","year":"2005","unstructured":"Glass DA, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751\u2013764. https:\/\/doi.org\/10.1016\/j.devcel.2005.02.017","journal-title":"Dev Cell"},{"key":"6288_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00774-009-0064-8","volume":"27","author":"T Kubota","year":"2009","unstructured":"Kubota T, Michigami T, Ozono K (2009) Wnt signaling in bone metabolism. J Bone Miner Metab 27:265\u2013271. https:\/\/doi.org\/10.1007\/s00774-009-0064-8","journal-title":"J Bone Miner Metab"},{"key":"6288_CR27","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.1071549","volume":"296","author":"RT Moon","year":"2002","unstructured":"Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296:1644\u20131646. https:\/\/doi.org\/10.1126\/science.1071549","journal-title":"Science"},{"key":"6288_CR28","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms20225525","volume":"20","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kobayashi Y, Koide M et al (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci 20:5525. https:\/\/doi.org\/10.3390\/ijms20225525","journal-title":"Int J Mol Sci"},{"key":"6288_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","volume":"341","author":"JJ Westendorf","year":"2004","unstructured":"Westendorf JJ, Kahler RA, Schroeder TM (2004) Wnt signaling in osteoblasts and bone diseases. Gene 341:19\u201339. https:\/\/doi.org\/10.1016\/j.gene.2004.06.044","journal-title":"Gene"},{"key":"6288_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/35035117","volume":"407","author":"K Tamai","year":"2000","unstructured":"Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530\u2013535. https:\/\/doi.org\/10.1038\/35035117","journal-title":"Nature"},{"key":"6288_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781\u2013810. https:\/\/doi.org\/10.1146\/annurev.cellbio.20.010403.113126","journal-title":"Annu Rev Cell Dev Biol"},{"key":"6288_CR32","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.cellsig.2013.04.002","volume":"25","author":"CG Miao","year":"2013","unstructured":"Miao CG, Yang YY, He X, Li XF, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J (2013) Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal 25:2069\u20132078. https:\/\/doi.org\/10.1016\/j.cellsig.2013.04.002","journal-title":"Cell Signal"},{"key":"6288_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00109-012-0974-0","volume":"91","author":"K Maeda","year":"2013","unstructured":"Maeda K, Takahashi N, Kobayashi Y (2013) Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl) 91:15\u201323. https:\/\/doi.org\/10.1007\/s00109-012-0974-0","journal-title":"J Mol Med (Berl)"},{"key":"6288_CR34","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00018-016-2425-5","volume":"74","author":"CM Karner","year":"2017","unstructured":"Karner CM, Long F (2017) Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci 74:1649\u20131657. https:\/\/doi.org\/10.1007\/s00018-016-2425-5","journal-title":"Cell Mol Life Sci"},{"key":"6288_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","volume":"10","author":"SG Pai","year":"2017","unstructured":"Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ (2017) Wnt\/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10:101. https:\/\/doi.org\/10.1186\/s13045-017-0471-6","journal-title":"J Hematol Oncol"},{"key":"6288_CR36","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1359\/JBMR.040816","volume":"19","author":"ML Johnson","year":"2004","unstructured":"Johnson ML, Harnish K, Nusse R, Van Hul W (2004) LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19:1749\u20131757. https:\/\/doi.org\/10.1359\/JBMR.040816","journal-title":"J Bone Miner Res"},{"key":"6288_CR37","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerina K, Baum W, Kireva T, Distler JH, Grisanti M, Asuncion F, Li X, Ominsky M, Richards W, Schett G, Zwerina J (2010) Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 69:2152\u20132159. https:\/\/doi.org\/10.1136\/ard.2010.132852","journal-title":"Ann Rheum Dis"},{"key":"6288_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","volume":"68","author":"N Maruotti","year":"2012","unstructured":"Maruotti N, Corrado A, Neve A, Cantatore FP (2012) Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol 68:1013\u20131018. https:\/\/doi.org\/10.1007\/s00228-012-1216-7","journal-title":"Eur J Clin Pharmacol"},{"key":"6288_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s007740070018","volume":"18","author":"T Tsurukai","year":"2000","unstructured":"Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T (2000) Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J Bone Miner Metab 18:177\u2013184. https:\/\/doi.org\/10.1007\/s007740070018","journal-title":"J Bone Miner Metab"},{"key":"6288_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1172\/JCI16924","volume":"111","author":"R Faccio","year":"2003","unstructured":"Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL (2003) c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest 111:749\u2013758. https:\/\/doi.org\/10.1172\/JCI16924","journal-title":"J Clin Invest"},{"key":"6288_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342. https:\/\/doi.org\/10.1038\/nature01658","journal-title":"Nature"},{"key":"6288_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1172\/JCI23394vol","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115:282\u2013290. https:\/\/doi.org\/10.1172\/JCI23394vol","journal-title":"J Clin Invest"},{"key":"6288_CR43","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1002\/jcp.26024no","volume":"232","author":"Y Cao","year":"2017","unstructured":"Cao Y, Jansen IDC, Sprangers S, de Vries TJ, Everts V (2017) TNF-\u03b1 has both stimulatory and inhibitory effects on mouse monocyte-derived osteoclastogenesis. J Cell Physiol 232:3273\u20133285. https:\/\/doi.org\/10.1002\/jcp.26024no","journal-title":"J Cell Physiol"},{"key":"6288_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcb.1202","volume":"83","author":"W Zou","year":"2001","unstructured":"Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z (2001) Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83:70\u201383. https:\/\/doi.org\/10.1002\/jcb.1202","journal-title":"J Cell Biochem"},{"key":"6288_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbrc.2007.04.058","volume":"357","author":"A Nakao","year":"2007","unstructured":"Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K (2007) RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways. Biochem Biophys Res Commun 357:945\u2013950. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.058","journal-title":"Biochem Biophys Res Commun"},{"key":"6288_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251\u2013264. https:\/\/doi.org\/10.1016\/j.bone.2006.09.023","journal-title":"Bone"},{"key":"6288_CR47","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1152\/physrev.00028.2017","volume":"98","author":"JW Lowery","year":"2018","unstructured":"Lowery JW, Rosen V (2018) The BMP pathway and its inhibitors in the skeleton. Physiol Rev 98:2431\u20132452. https:\/\/doi.org\/10.1152\/physrev.00028.2017","journal-title":"Physiol Rev"},{"key":"6288_CR48","doi-asserted-by":"publisher","first-page":"29119","DOI":"10.1074\/jbc.M801774200","volume":"283","author":"T Matsubara","year":"2008","unstructured":"Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119\u201329125. https:\/\/doi.org\/10.1074\/jbc.M801774200","journal-title":"J Biol Chem"},{"key":"6288_CR49","doi-asserted-by":"publisher","first-page":"a022095","DOI":"10.1101\/cshperspect.a022095","volume":"9","author":"K Miyazawa","year":"2017","unstructured":"Miyazawa K, Miyazono K (2017) Regulation of TGF-\u03b2 family signaling by inhibitory smads. Cold Spring Harb Perspect Biol 9:a022095. https:\/\/doi.org\/10.1101\/cshperspect.a022095","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6288_CR50","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1172\/JCI3459","volume":"102","author":"E Gazzerro","year":"1998","unstructured":"Gazzerro E, Gangji V, Canalis E (1998) Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102:2106\u20132114. https:\/\/doi.org\/10.1172\/JCI3459","journal-title":"J Clin Invest"},{"key":"6288_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","volume":"8","author":"JB Lian","year":"2012","unstructured":"Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, Zhang Y (2012) MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8:212\u2013227. https:\/\/doi.org\/10.1038\/nrendo.2011.234","journal-title":"Nat Rev Endocrinol"},{"key":"6288_CR52","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.17219\/acem\/104533","volume":"28","author":"F Zhang","year":"2019","unstructured":"Zhang F, Cao K, Du G, Zhang Q, Yin Z (2019) miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt\/\u03b2-catenin signaling pathway. Adv Clin Exp Med 28:1293\u20131300. https:\/\/doi.org\/10.17219\/acem\/104533","journal-title":"Adv Clin Exp Med"},{"key":"6288_CR53","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1002\/jcp.26596","volume":"233","author":"Y Luo","year":"2018","unstructured":"Luo Y, Cao X, Chen J, Gu J, Zhao J, Sun J (2018) MicroRNA-224 suppresses osteoblast differentiation by inhibiting SMAD4. J Cell Physiol 233:6929\u20136937. https:\/\/doi.org\/10.1002\/jcp.26596","journal-title":"J Cell Physiol"},{"key":"6288_CR54","doi-asserted-by":"publisher","first-page":"600867","DOI":"10.3389\/fcell.2020.600867","volume":"8","author":"H Zhao","year":"2020","unstructured":"Zhao H, Lu A, He X (2020) Roles of microRNAs in bone destruction of rheumatoid arthritris. Front Cell Dev Biol 8:600867. https:\/\/doi.org\/10.3389\/fcell.2020.600867","journal-title":"Front Cell Dev Biol"},{"key":"6288_CR55","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G (2015) Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis 74:2151\u20132156. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205428","journal-title":"Ann Rheum Dis"},{"key":"6288_CR56","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/annrheumdis-2014-206623","volume":"74","author":"HW van Steenbergen","year":"2015","unstructured":"van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AH (2015) The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis. Ann Rheum Dis 74:e3. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206623","journal-title":"Ann Rheum Dis"},{"key":"6288_CR57","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G (2014) Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 73:854\u2013860. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202958","journal-title":"Ann Rheum Dis"},{"key":"6288_CR58","doi-asserted-by":"publisher","first-page":"728610","DOI":"10.1155\/2015\/728610","volume":"2015","author":"AA Jilani","year":"2015","unstructured":"Jilani AA, Mackworth-Young CG (2015) The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. Int J Rheumatol 2015:728610. https:\/\/doi.org\/10.1155\/2015\/728610","journal-title":"Int J Rheumatol"},{"key":"6288_CR59","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791\u20131802. https:\/\/doi.org\/10.1172\/JCI60975","journal-title":"J Clin Invest"},{"key":"6288_CR60","first-page":"304","volume":"18","author":"PK Panagopoulos","year":"2018","unstructured":"Panagopoulos PK, Lambrou GI (2018) Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications. J Musculoskelet Neuronal Interact 18:304\u2013319","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"6288_CR61","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/ar1943","volume":"8","author":"H Ideguchi","year":"2006","unstructured":"Ideguchi H, Ohno S, Hattori H, Senuma A, Ishigatsubo Y (2006) Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther 8:R76. https:\/\/doi.org\/10.1186\/ar1943","journal-title":"Arthritis Res Ther"},{"key":"6288_CR62","first-page":"3317","volume":"11","author":"W Zheng","year":"2019","unstructured":"Zheng W, Gu X, Hu D, Hao Y (2019) Co-culture with synovial tissue in patients with rheumatoid arthritis suppress cell proliferation by regulating MAPK pathway in osteoblasts. Am J Transl Res 11:3317\u20133327","journal-title":"Am J Transl Res"},{"key":"6288_CR63","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","volume":"141","author":"L Gilbert","year":"2000","unstructured":"Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141:3956\u20133964. https:\/\/doi.org\/10.1210\/endo.141.11.7739","journal-title":"Endocrinology"},{"key":"6288_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12979","volume":"189","author":"C Wehmeyer","year":"2017","unstructured":"Wehmeyer C, Pap T, Buckley CD, Naylor AJ (2017) The role of stromal cells in inflammatory bone loss. Clin Exp Immunol 189:1\u201311. https:\/\/doi.org\/10.1111\/cei.12979","journal-title":"Clin Exp Immunol"},{"key":"6288_CR65","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1074\/jbc.M106339200","volume":"277","author":"L Gilbert","year":"2002","unstructured":"Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277:2695\u20132701. https:\/\/doi.org\/10.1074\/jbc.M106339200","journal-title":"J Biol Chem"},{"key":"6288_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163. https:\/\/doi.org\/10.1038\/nm1538","journal-title":"Nat Med"},{"key":"6288_CR67","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3899\/jrheum.081321","volume":"36","author":"E Musacchio","year":"2009","unstructured":"Musacchio E, Valvason C, Botsios C, Ostuni F, Furlan A, Ramonda R, Modesti V, Sartori L, Punzi L (2009) The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. J Rheumatol 36:1575\u20131579. https:\/\/doi.org\/10.3899\/jrheum.081321","journal-title":"J Rheumatol"},{"key":"6288_CR68","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/en.2004-1167","volume":"146","author":"XH Liu","year":"2005","unstructured":"Liu XH, Kirschenbaum A, Yao S, Levine AC (2005) Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-{kappa}B (RANK) ligand\/RANK system. Endocrinology 146:1991\u20131998. https:\/\/doi.org\/10.1210\/en.2004-1167","journal-title":"Endocrinology"},{"key":"6288_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3325\/cmj.2016.57.89","volume":"57","author":"K Malysheva","year":"2016","unstructured":"Malysheva K, de Rooij K, Lowik CW et al (2016) Interleukin 6\/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts. Croat Med J 57:89\u201398. https:\/\/doi.org\/10.3325\/cmj.2016.57.89","journal-title":"Croat Med J"},{"key":"6288_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s8756-3282(97)00038-0","volume":"21","author":"T Nakase","year":"1997","unstructured":"Nakase T, Takaoka K, Masuhara K, Shimizu K, Yoshikawa H, Ochi T (1997) Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 21:17\u201321. https:\/\/doi.org\/10.1016\/s8756-3282(97)00038-0","journal-title":"Bone"},{"key":"6288_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/03009742.2015.1126347","volume":"45","author":"MM Matzelle","year":"2016","unstructured":"Matzelle MM, Shaw AT, Baum R et al (2016) Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation. Scand J Rheumatol 45:379\u2013383. https:\/\/doi.org\/10.3109\/03009742.2015.1126347","journal-title":"Scand J Rheumatol"},{"key":"6288_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.peptides.2015.09.007","volume":"73","author":"T Katsuyama","year":"2015","unstructured":"Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H (2015) Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-\u03b1 on osteoblast marker expression induced by bone morphogenetic protein-2. Peptides 73:88\u201394. https:\/\/doi.org\/10.1016\/j.peptides.2015.09.007","journal-title":"Peptides"},{"key":"6288_CR73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.24418","volume":"114","author":"MB Ellman","year":"2013","unstructured":"Ellman MB, Yan D, Ahmadinia K, Chen D, An HS, Im HJ (2013) Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem 114:735\u2013742. https:\/\/doi.org\/10.1002\/jcb.24418","journal-title":"J Cell Biochem"},{"key":"6288_CR74","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/en.2005-1502","volume":"147","author":"MP Valta","year":"2006","unstructured":"Valta MP, Hentunen T, Qu Q, Valve EM, Harjula A, Sepp\u00e4nen JA, V\u00e4\u00e4n\u00e4nen HK, H\u00e4rk\u00f6nen PL (2006) Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. Endocrinology 147:2171\u20132182. https:\/\/doi.org\/10.1210\/en.2005-1502","journal-title":"Endocrinology"},{"key":"6288_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/ard.2007.080127","volume":"68","author":"PC Verschueren","year":"2009","unstructured":"Verschueren PC, Lories RJ, Daans M, Th\u00e9ate I, Durez P, Westhovens R, Luyten FP (2009) Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 68:117\u2013123. https:\/\/doi.org\/10.1136\/ard.2007.080127","journal-title":"Ann Rheum Dis"},{"key":"6288_CR76","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3109\/14653249.2012.681039","volume":"14","author":"H Schmal","year":"2012","unstructured":"Schmal H, Pilz IH, Mehlhorn AT, Dovi-Akue D, Kirchhoff C, S\u00fcdkamp NP, Gerlach U, Niemeyer P (2012) Expression of BMP-receptor type 1A correlates with progress of osteoarthritis in human knee joints with focal cartilage lesions. Cytotherapy 14:868\u2013876. https:\/\/doi.org\/10.3109\/14653249.2012.681039","journal-title":"Cytotherapy"},{"key":"6288_CR77","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.yexcr.2006.02.007","volume":"312","author":"JC Utting","year":"2006","unstructured":"Utting JC, Robins SP, Brandao-Burch A, Orriss IR, Behar J, Arnett TR (2006) Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 312:1693\u20131702. https:\/\/doi.org\/10.1016\/j.yexcr.2006.02.007","journal-title":"Exp Cell Res"},{"key":"6288_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0285-8","volume":"77","author":"A Brandao-Burch","year":"2005","unstructured":"Brandao-Burch A, Utting JC, Orriss IR, Arnett TR (2005) Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int 77:167\u2013174. https:\/\/doi.org\/10.1007\/s00223-004-0285-8","journal-title":"Calcif Tissue Int"},{"key":"6288_CR79","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1182\/blood-2006-11-056747","volume":"109","author":"S Colla","year":"2007","unstructured":"Colla S, Zhan F, Xiong W, Wu X, Xu H, Stephens O, Yaccoby S, Epstein J, Barlogie B, Shaughnessy JD Jr (2007) The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells. Blood 109:4470\u20134477. https:\/\/doi.org\/10.1182\/blood-2006-11-056747","journal-title":"Blood"},{"key":"6288_CR80","doi-asserted-by":"publisher","first-page":"27298","DOI":"10.1074\/jbc.M702811200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida M, Han L, Martin-Millan M, O\u2019Brien CA, Manolagas SC (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282:27298\u201327305. https:\/\/doi.org\/10.1074\/jbc.M702811200","journal-title":"J Biol Chem"},{"key":"6288_CR81","doi-asserted-by":"publisher","first-page":"105810","DOI":"10.1016\/j.intimp.2019.105810","volume":"75","author":"Y Li","year":"2019","unstructured":"Li Y, Yuan L, Jiang S, Liu S, Xia L, Shen H, Lu J (2019) Interleukin-35 stimulates tumor necrosis factor-\u03b1 activated osteoblasts differentiation through Wnt\/\u03b2-catenin signaling pathway in rheumatoid arthritis. Int Immunopharmacol 75:105810. https:\/\/doi.org\/10.1016\/j.intimp.2019.105810","journal-title":"Int Immunopharmacol"},{"key":"6288_CR82","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1172\/JCI68901","volume":"124","author":"H Zhang","year":"2014","unstructured":"Zhang H, Hilton MJ, Anolik JH et al (2014) NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-\u03baB. J Clin Invest 124:3200\u20133214. https:\/\/doi.org\/10.1172\/JCI68901","journal-title":"J Clin Invest"},{"key":"6288_CR83","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, Yamamoto M (2016) Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7:11624. https:\/\/doi.org\/10.1038\/ncomms11624","journal-title":"Nat Commun"},{"key":"6288_CR84","doi-asserted-by":"publisher","first-page":"23009","DOI":"10.1074\/jbc.M113.478545","volume":"288","author":"H Kanzaki","year":"2013","unstructured":"Kanzaki H, Shinohara F, Kajiya M, Kodama T (2013) The Keap1\/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem 288:23009\u201323020. https:\/\/doi.org\/10.1074\/jbc.M113.478545","journal-title":"J Biol Chem"},{"key":"6288_CR85","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.bonr.2019.100228","volume":"11","author":"T Narimiya","year":"2019","unstructured":"Narimiya T, Kanzaki H, Yamaguchi Y et al (2019) Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression. Bone Rep 11:100228. https:\/\/doi.org\/10.1016\/j.bonr.2019.100228","journal-title":"Bone Rep"},{"key":"6288_CR86","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/BOR.0b013e3283369cb8","volume":"22","author":"B Marston","year":"2010","unstructured":"Marston B, Palanichamy A, Anolik JH (2010) B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 22:307\u2013315. https:\/\/doi.org\/10.1097\/BOR.0b013e3283369cb8","journal-title":"Curr Opin Rheumatol"},{"key":"6288_CR87","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-018-07626-8","volume":"9","author":"W Sun","year":"2018","unstructured":"Sun W, Meednu N, Rosenberg A, Rangel-Moreno J, Wang V, Glanzman J, Owen T, Zhou X, Zhang H, Boyce BF, Anolik JH, Xing L (2018) B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation. Nat Commun 9:5127. https:\/\/doi.org\/10.1038\/s41467-018-07626-8","journal-title":"Nat Commun"},{"key":"6288_CR88","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907\u2013916. https:\/\/doi.org\/10.1056\/NEJM200103223441207","journal-title":"N Engl J Med"},{"key":"6288_CR89","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20071493","volume":"409","author":"M O'Hayre","year":"2008","unstructured":"O\u2019Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409:635\u2013649. https:\/\/doi.org\/10.1042\/BJ20071493","journal-title":"Biochem J"},{"key":"6288_CR90","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI115950","volume":"90","author":"AE Koch","year":"1992","unstructured":"Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90:772\u2013779. https:\/\/doi.org\/10.1172\/JCI115950","journal-title":"J Clin Invest"},{"key":"6288_CR91","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.1780360605","volume":"36","author":"T Akahoshi","year":"1993","unstructured":"Akahoshi T, Wada C, Endo H, Hirota K, Hosaka S, Takagishi K, Kondo H, Kashiwazaki S, Matsushima K (1993) Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor. Arthritis Rheum 36:762\u2013771. https:\/\/doi.org\/10.1002\/art.1780360605","journal-title":"Arthritis Rheum"},{"key":"6288_CR92","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","volume":"68","author":"LF Lau","year":"2001","unstructured":"Lau LF (2001) CCN1\/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68:3149\u20133163. https:\/\/doi.org\/10.1007\/s00018-011-0778-3","journal-title":"Cell Mol Life Sci"},{"key":"6288_CR93","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41598-017-00513-0","volume":"7","author":"CY Chen","year":"2017","unstructured":"Chen CY, Fuh LJ, Huang CC, Hsu CJ, Su CM, Liu SC, Lin YM, Tang CH (2017) Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy. Sci Rep 7:421. https:\/\/doi.org\/10.1038\/s41598-017-00513-0","journal-title":"Sci Rep"},{"key":"6288_CR94","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3389\/fimmu.2018.01417","volume":"9","author":"M Peng","year":"2018","unstructured":"Peng M, Wang Y, Qiang L, Xu Y, Li C, Li T, Zhou X, Xiao M, Wang J (2018) Interleukin-35 Inhibits TNF-\u03b1-Induced osteoclastogenesis and promotes apoptosis via shifting the activation from TNF Receptor-Associated Death Domain (TRADD)-TRAF2 to TRADD-Fas-associated death domain by JAK1\/STAT1. Front Immunol 9:1417. https:\/\/doi.org\/10.3389\/fimmu.2018.01417","journal-title":"Front Immunol"},{"key":"6288_CR95","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/08923973.2019.1610429","volume":"41","author":"N Yuan","year":"2019","unstructured":"Yuan N, Yu G, Liu D, Wang X, Zhao L (2019) An emerging role of interleukin-23 in rheumatoid arthritis. Immunopharmacol Immunotoxicol 41:185\u2013191. https:\/\/doi.org\/10.1080\/08923973.2019.1610429","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"6288_CR96","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.4049\/jimmunol.181.8.5720","volume":"181","author":"JM Quinn","year":"2008","unstructured":"Quinn JM, Sims NA, Saleh H, Mirosa D, Thompson K, Bouralexis S, Walker EC, Martin TJ, Gillespie MT (2008) IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J Immunol 181:5720\u20135729. https:\/\/doi.org\/10.4049\/jimmunol.181.8.5720","journal-title":"J Immunol"},{"key":"6288_CR97","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-007-0766-8","volume":"25","author":"S Kamiya","year":"2007","unstructured":"Kamiya S, Nakamura C, Fukawa T, Ono K, Ohwaki T, Yoshimoto T, Wada S (2007) Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. J Bone Miner Metab 25:277\u2013285. https:\/\/doi.org\/10.1007\/s00774-007-0766-8","journal-title":"J Bone Miner Metab"},{"key":"6288_CR98","doi-asserted-by":"publisher","first-page":"9149762","DOI":"10.1155\/2020\/9149762","volume":"2020","author":"AR Ginting","year":"2020","unstructured":"Ginting AR, Hidayat R, Sumariyono S, Koesnoe S (2020) Role of secreted frizzled-related protein 1 and tumor necrosis factor-\u03b1 (TNF-\u03b1) in bone loss of patients with rheumatoid arthritis. Int J Rheumatol 2020:9149762. https:\/\/doi.org\/10.1155\/2020\/9149762","journal-title":"Int J Rheumatol"},{"key":"6288_CR99","doi-asserted-by":"publisher","first-page":"625034","DOI":"10.3389\/fimmu.2020.625034","volume":"11","author":"M Tang","year":"2021","unstructured":"Tang M, Lu L, Yu X (2021) Interleukin-17A interweaves the skeletal and immune systems. Front Immunol 11:625034. https:\/\/doi.org\/10.3389\/fimmu.2020.625034","journal-title":"Front Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06288-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T10:08:40Z","timestamp":1618999720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06288-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["6288"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06288-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}